Study presents novel treatment strategy to tackle metastatic intra-abdominal cancer (PAI-1 mediated, which Vitamin C & E may influence)

Medical Xpress / SingHealth / Cell Reports Medicine ^ | Feb. 15, 2022 | Chin-Ann J. Ong et al

[ConservativeMind]

Researchers have found a potential new strategy to treat peritoneal carcinomatosis, a metastatic form of intra-abdominal cancer, where patients are presented with limited treatment options and poor overall survival. The findings provide a way to identify more effective treatments for patients with metastatic intra-abdominal cancers by targeting what fuels cancer cells.

A widely accepted scientific hypothesis is that cancer ("seed") spreads onto the organ surfaces ("soil") through a series of complex interactions in the body. Most cancer treatments directly target the "seed" such as through the use of chemotherapy, which inhibits cancer cell division. In the last nine years, immunotherapy has become increasingly popular as a means of cancer treatment, altering the "soil" by enlisting the body's immune system to target cancer cells. In this latest research, findings show it is possible to target "water" to create an arid environment thus making it inhospitable for tumor cell growth.

The team identified that ascites, excess fluid ("water") present in the abdomen of patients with metastatic intra-abdominal cancers, can be directly targeted to remove the fuel that drives cancer growth. By interrogating the proteins in ascites, the team found that PAI-1 (plasminogen activator inhibitor 1) is a good marker of response to direct inhibition and could potentially curb cancer cell proliferation. Prior to the team's discovery, PAI-1 was not known to be related to the growth of intra-abdominal cancers.

Using biological samples, Asst Prof Ong identified a panel of three biomarkers that could predict patient outcomes as well as responsiveness to PAI-1 therapy. The findings were confirmed with models incorporating the tripartite combination of "seed," "soil" and "water."

"Our study not only highlights a novel treatment strategy for peritoneal carcinomatosis, it also provides the foundation for the development of a new translational research therapeutic program at NCCS." said Asst Prof Ong.

[ConservativeMind]

An older study provides insight on PAI-1 (plasminogen activator inhibitor 1) and the ability of Vitamin C and E to “significantly” reduce “plasma PAI-1 activity” and attenuate “the inhibitor expression.”

[ConservativeMind]

The prior study:

Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty

https://pubmed.ncbi.nlm.nih.gov/11164859/

[ConservativeMind]

The “Take Charge Of Your Health” Ping List

This potentially high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to implement for your benefit.

Please email or private message me if you want on or off of this list.